IPPRA / Grant Monitor

2026-07-07
← Board

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

PAR-25-101 · National Institutes of Health

biomedical clinical mental behavioral health public health Education Health

Closes
2027-08-11 · 400 d
Award ceiling
$150,000
Award floor
Program funding
$150,000
Expected awards
Cost sharing
No
Posted
2024-12-30
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

NIH/NIDA R21 grants for highly innovative basic or mechanistic research on substance use disorders, including novel methods or high-risk hypotheses with little preliminary data, for eligible domestic or foreign applicants.

Funds
basic research
University
direct
social behavioral
substantial
physical sciences
minor
engineering
minor
life biomedical
central
computational data
minor

⚑ R21 Clinical Trial Optional · High-risk/high-impact exploratory award; award ceiling $150,000 · Foreign organizations and several special institution classes are explicitly eligible · Focus is NIDA basic research on etiology, pathophysiology, prevention, or treatment of SUDs; applications should be sparse or outside current portfolio

Unit fits — one characterization, each unit's own rules

IPPRA 58 good peripheral portfolio topic: public_health; social/behavioral work is substantial; funds basic research; biomedical core — IPPRA health lane is communication/crisis/policy (capped); clinical-trial/biomedical core — IPPRA angle is policy/community (capped)
Physical Sciences & Engineering (demo) 55 good technical depth: minor; funds basic research
Tom Love Innovation Hub 15 none deep-tech content; no commercialization signal

Description

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Apply

View on Grants.gov → CONTACT: National Institutes of Health <grantsinfo@nih.gov>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · National Institutes of Health conventions SEE AN NIH EXAMPLE →

Funder-faithful document skeletons — National Institutes of Health's document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING